[Index of tumor response by in-vivo 31P-MRS--T1 effect as a new predicting index of therapeutic effects].
We observed the metabolism of the Yoshida sarcoma by in-vivo 31P-MRS, using two varieties of repetition time (TR), i.e., TR2s and TR10s. It was measured before the injection of 5FU and 4, 24, 48 hours after the injection. In the each time, PME/ATP ratio, intracellular pH, and TR10/TR2 ratio of PME which reflects the T1 value of PME, were calculated. TR10/TR2 ratio of PME decreased 4 and 24 hours after the injection of 5FU and recovered 48 hours after the injection to the same level before the injection. However decrease of PME/ATP ratio was not observed until 48 hours after the injection of 5FU, when apparent tumor regression appeared. These results suggested that the T1 value of PME decreased prior to the PME changes and when the PME decreased, the intracellular environment of PME recovered to the same state before the therapy. It was considered that the TR10/TR2 ratio of PME offers significant information different from the PME/ATP ratio. It is possible to use the TR10/TR2 ratio as a predicting index for the therapeutic effects.
Harada
M
M
Department of Radiology, School of Medicine, University of Tokushima.
Nishitani
H
H
Shiramhama
T
T
Koga
K
K
Miura
I
I
D000818:Animals; D005472:Fluorouracil / Q000627:therapeutic use; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D010758:Phosphorus; D011237:Predictive Value of Tests; D051381:Rats; D011919:Rats, Inbred Strains; D012074:Remission Induction; D012517:Sarcoma, Yoshida / Q000175:diagnosis* / Q000188:drug therapy
D010758:Phosphorus; D005472:Fluorouracil